News: Alexion Pharmaceuticals Inc (ALXN.O)

ALXN.O on Nasdaq

163.84USD
29 May 2015
Change (% chg)

$-2.35 (-1.41%)
Prev Close
$166.19
Open
$165.59
Day's High
$166.66
Day's Low
$162.27
Volume
1,724,626
Avg. Vol
1,795,749
52-wk High
$203.30
52-wk Low
$150.06

Search Stocks
Select another date:

Wed, May 6 2015

Alexion to bolster rare disease offering with $8.4 billion deal

- Alexion Pharmaceuticals Inc on Wednesday said it agreed to buy Synageva BioPharma Corp for $8.4 billion, more than twice its market value, to expand its offering of potentially high-priced medicines for rare diseases. | Video

Rich Synageva M&A premium epitomizes appetite for orphan drugs

- The hefty premium Alexion Pharmaceuticals Inc has agreed to pay to acquire Synageva BioPharma Corp highlights how the popularity of so-called orphan drug makers is leading to valuations many investors now deem frothy.

CORRECTED-Rich Synageva M&A premium epitomizes appetite for orphan drugs

May 6 - The hefty premium Alexion Pharmaceuticals Inc has agreed to pay to acquire Synageva BioPharma Corp highlights how the popularity of so-called orphan drug makers is leading to valuations many investors now deem frothy.

Deals of the day- Mergers and acquisitions

May 6 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Wednesday:

UPDATE 4-Alexion to bolster rare disease offering with $8.4 bln deal

* Alexion offers $225.92 per Synageva share in cash and stock

Select another date:
Search Stocks